110 related articles for article (PubMed ID: 3474057)
1. Molecular characteristics of chronic myelogenous leukemia in blast crisis.
Blick M; Romero P; Talpaz M; Kurzrock R; Shtalrid M; Andersson B; Trujillo J; Beran M; Gutterman J
Cancer Genet Cytogenet; 1987 Aug; 27(2):349-56. PubMed ID: 3474057
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity in expression of the bcr-abl fusion transcript in CML blast crisis.
Andrews DF; Collins SJ
Leukemia; 1987 Oct; 1(10):718-24. PubMed ID: 3312834
[TBL] [Abstract][Full Text] [Related]
3. Persistence of chronic myelocytic leukemia despite deletion of rearranged bcr/c-abl sequences in blast crisis.
Bartram CR; Janssen JW; Becher R; de Klein A; Grosveld G
J Exp Med; 1986 Nov; 164(5):1389-96. PubMed ID: 3464689
[TBL] [Abstract][Full Text] [Related]
4. Chronic myelogenous leukemia: amplification of a rearranged c-abl oncogene in both chronic phase and blast crisis.
Collins SJ; Groudine MT
Blood; 1987 Mar; 69(3):893-8. PubMed ID: 3545323
[TBL] [Abstract][Full Text] [Related]
5. Acquired homozygosity of the rearranged bcr allele during the acute leukemic phase of a patient with Ph-negative chronic myeloid leukemia.
Reeve AE; Morris CM; Fitzgerald PH
Blood; 1988 Jul; 72(1):24-8. PubMed ID: 3164635
[TBL] [Abstract][Full Text] [Related]
6. Transposition of c-abl oncogene in a case of masked Ph chromosome duplicated in blastic phase.
Maserati E; Cavalli P; Casalone R; Morandi S; Pasquali F
Hum Genet; 1988 Mar; 78(3):248-50. PubMed ID: 3162225
[TBL] [Abstract][Full Text] [Related]
7. [Molecular analysis of transformation into blast crisis in chronic myelogenous leukemia].
Okabe M
Hokkaido Igaku Zasshi; 1993 Mar; 68(2):237-50. PubMed ID: 8509066
[TBL] [Abstract][Full Text] [Related]
8. Activation of EVI1 transcription by the LEF1/β-catenin complex with p53-alteration in myeloid blast crisis of chronic myeloid leukemia.
Manachai N; Saito Y; Nakahata S; Bahirvani AG; Osato M; Morishita K
Biochem Biophys Res Commun; 2017 Jan; 482(4):994-1000. PubMed ID: 27908728
[TBL] [Abstract][Full Text] [Related]
9. Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation.
Wetzler M; Talpaz M; Van Etten RA; Hirsh-Ginsberg C; Beran M; Kurzrock R
J Clin Invest; 1993 Oct; 92(4):1925-39. PubMed ID: 8408645
[TBL] [Abstract][Full Text] [Related]
10. Polymorphism of the human c-abl gene: relation to incidence and course of chronic myelogenous leukemia.
Daniel L; Ahmed CM; Bloodgood RS; Kidd JR; Castiglione CM; Duttagupta S; Lebowitz P
Oncogene; 1987 May; 1(2):193-200. PubMed ID: 2894000
[TBL] [Abstract][Full Text] [Related]
11. [Molecular genetics of the pathogenesis and classification of chronic myelocytic leukemia].
Bartram CR
Onkologie; 1987 Jun; 10(3):127-32. PubMed ID: 3306531
[TBL] [Abstract][Full Text] [Related]
12. Analysis of P210bcr-abl tyrosine protein kinase activity in various subtypes of Philadelphia chromosome-positive cells from chronic myelogenous leukemia patients.
Maxwell SA; Kurzrock R; Parsons SJ; Talpaz M; Gallick GE; Kloetzer WS; Arlinghaus RB; Kouttab NM; Keating MJ; Gutterman JU
Cancer Res; 1987 Mar; 47(6):1731-9. PubMed ID: 2434223
[TBL] [Abstract][Full Text] [Related]
13. Effect of differentiation-inducing agents on oncogene expression in a chronic myelogenous leukemia cell line.
Eisbruch A; Blick M; Evinger-Hodges MJ; Beran M; Andersson B; Gutterman JU; Kurzrock R
Cancer; 1988 Sep; 62(6):1171-8. PubMed ID: 3044574
[TBL] [Abstract][Full Text] [Related]
14. Expression of c-abl in Philadelphia-positive acute myelogenous leukemia.
Kurzrock R; Shtalrid M; Talpaz M; Kloetzer WS; Gutterman JU
Blood; 1987 Nov; 70(5):1584-8. PubMed ID: 3311207
[TBL] [Abstract][Full Text] [Related]
15. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.
Phan CL; Megat Baharuddin PJ; Chin LP; Zakaria Z; Yegappan S; Sathar J; Tan SM; Purushothaman V; Chang KM
Cancer Genet Cytogenet; 2008 Jan; 180(1):60-4. PubMed ID: 18068536
[TBL] [Abstract][Full Text] [Related]
16. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
[TBL] [Abstract][Full Text] [Related]
17. The molecular biology of chronic myeloid leukaemia.
Melo JV
Leukemia; 1996 May; 10(5):751-6. PubMed ID: 8656667
[TBL] [Abstract][Full Text] [Related]
18. Southern blot analysis of Bcr, N-ras, H-ras, c-myc and myb proto-oncogenes in blast crisis of chronic myelogenous leukemia.
Naoe T; Doi S; Yamanaka K; Naito K; Nitta M; Yamada K
Nihon Ketsueki Gakkai Zasshi; 1989 Feb; 52(1):32-7. PubMed ID: 2741649
[TBL] [Abstract][Full Text] [Related]
19. Altered transcription of the c-abl oncogene in K-562 and other chronic myelogenous leukemia cells.
Collins SJ; Kubonishi I; Miyoshi I; Groudine MT
Science; 1984 Jul; 225(4657):72-4. PubMed ID: 6587568
[TBL] [Abstract][Full Text] [Related]
20. Breakpoints on chromosomes 9 and 22 in Philadelphia chromosome-positive chronic myelogenous leukemia (CML). Amplification of rearranged c-abl oncogenes in CML blast crisis.
Collins SJ
J Clin Invest; 1986 Nov; 78(5):1392-6. PubMed ID: 3021820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
